Phosphorylated Tau Levels in Donated Blood
Eligible age
All ages
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Alzheimer's disease (AD) is characterized by the accumulation of tau pathology, and blood-based biomarkers such as phosphorylated tau-217 (pTau217) have been identified as sensitive and specific predictors of AD risk. Recent studies suggest that individuals with elevated pTau217 levels may be at increased risk for developing AD and cognitive dysfunction. This observational study will examine donated human plasma samples to determine whether some units of donated blood contain abnormally elevated pTau217 concentrations. The overarching goal is to evaluate whether transfusion of blood with higher pTau217 may pose risks to recipients and whether such units should be avoided in clinical use.
Sponsor: The University of Texas Health Science Center, Houston
You may qualify if…
- ✓ The plasma sample from donators.
You may not qualify if…
- ✕ None.
Where it's recruiting
Houston
Source: ClinicalTrials.gov · NCT07157839 · last updated 2026-02-11